Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637689 · ClinicalTrials.gov registry record
Improving Outcomes Assessment in Chronic GVHD
A clinical trial of Chronic Graft Versus Host Disease, sponsored by Fred Hutchinson Cancer Center.
- Active
- Registry status
- 601
- Enrollment target
- 9
- Study locations
NCT00637689 is a study of Chronic Graft Versus Host Disease that is active but no longer recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 601 participants, above the 96-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (526% higher). The trial reports 9 study locations across 9 states.
The verdict
NCT00637689, a study of Chronic Graft Versus Host Disease, is active but no longer recruiting, sponsored by Fred Hutchinson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 601 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to see if recent guidelines proposed by the National Institutes of Health for the diagnosis, staging, and response assessment of people with chronic GVHD can improve our understanding of this complication. We will accomplish our goals by studying a large number of people with chronic GVHD over several years using information collected from health care providers, patients, laboratory studies and diagnostic tests. Several transplant centers in the United States are collaborating on this project.
Conditions Studied
Study Locations (9)
California
- Stanford University - Stanford
Florida
- H. Lee Moffitt Cancer Center - Tampa
Massachusetts
- Dana-Farber Cancer Institute - Boston
Minnesota
- University of Minnesota - Minneapolis
Missouri
- Washington University School of Medicine - St Louis
New York
- Memorial Sloan Kettering - New York
Tennessee
- Vanderbilt University - Nashville
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2007-09 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00637689
The ClinicalTrials.gov registry entry for NCT00637689 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (526% higher). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Graft Versus Host Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00637689 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00637689 about?
NCT00637689 is a clinical study titled "Improving Outcomes Assessment in Chronic GVHD". The purpose of this study is to see if recent guidelines proposed by the National Institutes of Health for the diagnosis, staging, and response assessment of people with chronic GVHD can improve our understanding of this complication. We will accomplish our goals by studying a large number of people...
What is the current status of trial NCT00637689?
This trial is currently active not recruiting. The enrollment target is 601 participants. The study started on 2007-09. Estimated completion is 2027-02.
What conditions does trial NCT00637689 study?
This clinical trial studies the following conditions: Chronic Graft Versus Host Disease.
Who is sponsoring clinical trial NCT00637689?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00637689 being conducted?
This trial has 9 study locations across California, Florida, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Graft Versus Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
A Long-term Extension Study of PCI-32765 (Ibrutinib)
RECRUITING · Phase 3
-
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
RECRUITING
-
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
RECRUITING · Phase 2
-
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RECRUITING · Phase 2
-
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.